|
|
Top Story |
 |
Pharm Exec's Top 50 Companies |
Pharm Exec’s 16th annual listing of the top biopharma players may look placid on the surface, but, upon deeper inspection, does point to important transitions taking place in the larger business model.
... /Read more/ |
|
|
Advertisement |
Watch this brief video to hear how trusted case managers can drive patient adherence and better outcomes using in-home education and tele-health support.
Learn more |
Advertisement |
Breaking the Circle of Distrust with a Radical PLC Pricing Model
LIVE WEBCAST: Thursday, June 30, 2016 at 10 am EDT | 3 pm BST | 4 pm CEST
Free registration |
|
Advertisement |
Best Practices for Integrating Biomarkers
across the Drug Development Continuum
Live webinar: Wednesday, June 22, 2016 11 am EDT (8 am PST)
Register today |
|
From the Editor |
 |
Workplace Design That Delivers |
William Looney explores the power of workplace aesthetic on the intangibles of culture, morale—and corporate mission—in a visit to one big Pharma's unique US headquarters
... /Read more/ |
|
|
|
Calendar |
|
|
Advertisement |
Considering Biosimilars: A Panel Discussion Exploring Perceptions and Potential Adoption
On Demand
Learn more |
|
|
 |
Advertisement |
Strategic considerations for clinical development programs in emerging biopharma companies
On Demand
Learn more |
|
Industry update |
//Moncef Slaoui, GSK's Chairman, Vaccines, has announced that he will retire from the company next year.//Innovative Medicines Canada (Ottawa, ON) appointed Elaine Campbell as Interim President.//Contract research organization Chiltern (Wilmington, NC and Slough, UK) promoted Richard Pilnik to Chairman, succeeding Nick Thornton.// |
|
|
|
|